Stéphanie Da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Stéphanie Da Silva has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Afifa Ait-Belgnaoui
UMR 1331 TOXALIM INRA/INPT/UPS, Equipe de NeuroGastroentérologie et Nutrition, 180 chemin de Tournefeuille, 31027 Toulouse cedex 9, France
2 shared publications- Catherine Robbe-Masselot
Université de Lille
2 shared publications Christel Salvador-Cartier
UMR 1331 TOXALIM INRA/INPT/UPS, Equipe de NeuroGastroentérologie et Nutrition, 180 chemin de Tournefeuille, 31027 Toulouse cedex 9, France
2 shared publicationsMuriel Mercier-Bonin
Université de Toulouse, INSA, UPS, INP, LISBP, 135 Avenue de Rangueil, F-31077 Toulouse, France
2 shared publicationsMyriam Mercade-Loubière
Université de Toulouse, INSA, UPS, INP, LISBP, 135 Avenue de Rangueil, F-31077 Toulouse, France
2 shared publicationsPascal Loubière
Université de Toulouse, INSA, UPS, INP, LISBP, 135 Avenue de Rangueil, F-31077 Toulouse, France
2 shared publications
Latest Publications
- 31 March 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Conséquences d'un stress chronique sur la barrière de mucus intestinal chez le rat : effet du probiotique Lactobacillus farciminis
Si les modifications dans l’expression et les propriétés des mucines ont été largement décrites dans la physiopathologie des maladies inflammatoires chroniques de l’intestin, la caractérisation structurale et fonctionnelle de la barrière de mucus reste parcellaire dans le contexte micro-inflammatoire du syndrome de l’intestin irritable (SII). Par ailleurs, certains traitements probiotiques préviennent la rupture de l’intégrité de la barrière épithéliale intestinale, provoquée en conditions de stress mais peu de travaux décrivent leur influence sur les modifications de la structure du mucus, induites par le stress. Cette étude a comme objectifs d’évaluer chez le rat (i) si un stress chronique modifie le nombre de cellules à mucus et l’expression de la mucine Muc2, ainsi que la nature biochimique des mucines secrétées au niveau de l’iléon et du côlon, et plus particulièrement les O-glycanes, (ii) si un traitement probiotique (Lactobacillus farciminis) prévient les modifications du mucus potentiellement induites, (iii) si les effets observés sont en lien avec la capacité de colonisation in vivo de L. farciminis.Méthodes. Des rats Wistar mâles ont reçu L. farciminis ou une solution saline. Les animaux ont été soumis au stress d’évitement passif de l’eau (WAS) pendant 1h/jour ou à un stress fictif (contrôle), pendant les 4 derniers jours des traitements. Différents prélèvements ont été effectués au niveau de l’iléon et du côlon pour (i) des analyses sur coupes (immuno-marquage, nombre de cellules à mucus) et (ii) la détermination du profil de O-glycosylation des mucines. La morphologie de la couche de mucus a été évaluée par microscopie à force atomique (AFM). L. farciminis a été visualisé par "Fluorescence in situ Hybridization", confirmée par qPCR et son adhésion à la muqueuse a été déterminée par une méthode ex situ. La perméabilité paracellulaire et la sensibilité viscérale ont été évaluées.Résultats. Le WAS ne modifie pas le nombre de cellules à mucus ni l’expression de la mucine Muc2 aux niveaux iléal et colique. L’analyse par spectrométrie de masse a révélé que le stress induit des altérations de la O-glycosylation des mucines. Une augmentation marquée du degré de complexité des structures glycaniques a été observée, se traduisant par l’apparition de chaînes polylactosaminiques, sans modification toutefois du taux de sialylation et de sulfatation des mucines. La couche de mucus en condition de stress, observée par AFM, présente une morphologie aplatie et moins cohésive. L'hypothèse serait que les modifications structurales des O-glycanes influencent les interactions physico-chimiques entre les fibres de mucines, impactant de manière négative l’intégrité de la barrière de mucus. Cette altération de la couche de mucus s'accompagne d'un défaut de la barrière épithéliale et d'une hypersensibilité viscérale. L’administration de la souche probiotique prévient ces changements provoqués par le WAS. L. farciminis a été retrouvé au sein de l’iléon et du côlon. Par ailleurs, la présence de "Segmented Filamentous Bacteria" (SFB) a été mise en évidence, par FISH et microscopie électronique, au niveau de l’iléon sur l'ensemble des animaux testés. Le traitement par L. farciminis induit une diminution de la population des SFB aussi bien chez les animaux contrôles que stressés. Conclusion. Nous avons montré qu’un stress chronique chez le rat, outre les modifications fonctionnelles de l'épithélium intestinal (hyperperméabilité intestinale et hypersensibilité viscérale), altère la structure O-glycanique des mucines sans affecter l’expression de Muc2. Ces altérations se traduisent par une perte des propriétés cohésives de la couche de mucus. La souche probiotique L. farciminis, en prévenant l’ensemble des modifications induites par le stress, contribue au renforcement de la fonction barrière de l'intestin. Cette étude fournit un argumentaire complémentaire pour l’utilisation de cette souche dans le traitement du SII.
- 31 March 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Conséquences d'un stress chronique sur la barrière de mucus intestinal chez le rat : effet du probiotique Lactobacillus farciminis
Si les modifications dans l’expression et les propriétés des mucines ont été largement décrites dans la physiopathologie des maladies inflammatoires chroniques de l’intestin, la caractérisation structurale et fonctionnelle de la barrière de mucus reste parcellaire dans le contexte micro-inflammatoire du syndrome de l’intestin irritable (SII). Par ailleurs, certains traitements probiotiques préviennent la rupture de l’intégrité de la barrière épithéliale intestinale, provoquée en conditions de stress mais peu de travaux décrivent leur influence sur les modifications de la structure du mucus, induites par le stress. Cette étude a comme objectifs d’évaluer chez le rat (i) si un stress chronique modifie le nombre de cellules à mucus et l’expression de la mucine Muc2, ainsi que la nature biochimique des mucines secrétées au niveau de l’iléon et du côlon, et plus particulièrement les O-glycanes, (ii) si un traitement probiotique (Lactobacillus farciminis) prévient les modifications du mucus potentiellement induites, (iii) si les effets observés sont en lien avec la capacité de colonisation in vivo de L. farciminis.Méthodes. Des rats Wistar mâles ont reçu L. farciminis ou une solution saline. Les animaux ont été soumis au stress d’évitement passif de l’eau (WAS) pendant 1h/jour ou à un stress fictif (contrôle), pendant les 4 derniers jours des traitements. Différents prélèvements ont été effectués au niveau de l’iléon et du côlon pour (i) des analyses sur coupes (immuno-marquage, nombre de cellules à mucus) et (ii) la détermination du profil de O-glycosylation des mucines. La morphologie de la couche de mucus a été évaluée par microscopie à force atomique (AFM). L. farciminis a été visualisé par "Fluorescence in situ Hybridization", confirmée par qPCR et son adhésion à la muqueuse a été déterminée par une méthode ex situ. La perméabilité paracellulaire et la sensibilité viscérale ont été évaluées.Résultats. Le WAS ne modifie pas le nombre de cellules à mucus ni l’expression de la mucine Muc2 aux niveaux iléal et colique. L’analyse par spectrométrie de masse a révélé que le stress induit des altérations de la O-glycosylation des mucines. Une augmentation marquée du degré de complexité des structures glycaniques a été observée, se traduisant par l’apparition de chaînes polylactosaminiques, sans modification toutefois du taux de sialylation et de sulfatation des mucines. La couche de mucus en condition de stress, observée par AFM, présente une morphologie aplatie et moins cohésive. L'hypothèse serait que les modifications structurales des O-glycanes influencent les interactions physico-chimiques entre les fibres de mucines, impactant de manière négative l’intégrité de la barrière de mucus. Cette altération de la couche de mucus s'accompagne d'un défaut de la barrière épithéliale et d'une hypersensibilité viscérale. L’administration de la souche probiotique prévient ces changements provoqués par le WAS. L. farciminis a été retrouvé au sein de l’iléon et du côlon. Par ailleurs, la présence de "Segmented Filamentous Bacteria" (SFB) a été mise en évidence, par FISH et microscopie électronique, au niveau de l’iléon sur l'ensemble des animaux testés. Le traitement par L. farciminis induit une diminution de la population des SFB aussi bien chez les animaux contrôles que stressés. Conclusion. Nous avons montré qu’un stress chronique chez le rat, outre les modifications fonctionnelles de l'épithélium intestinal (hyperperméabilité intestinale et hypersensibilité viscérale), altère la structure O-glycanique des mucines sans affecter l’expression de Muc2. Ces altérations se traduisent par une perte des propriétés cohésives de la couche de mucus. La souche probiotique L. farciminis, en prévenant l’ensemble des modifications induites par le stress, contribue au renforcement de la fonction barrière de l'intestin. Cette étude fournit un argumentaire complémentaire pour l’utilisation de cette souche dans le traitement du SII.
- Open Access
The Candidate IBD Risk Gene CCNY Is Dispensable for Intestinal Epithelial Homeostasis
The CCNY gene, which encodes cyclin Y, has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Cyclin Y promotes Wnt/β-catenin signaling and autophagy, which are critical for intestinal epithelial cell (IEC) homeostasis, and may thereby contribute to wound repair in colitis. However, whether cyclin Y has an essential function in IECs is unknown. We, therefore, investigated the epithelial injury response and mucosal regeneration in mice with conditional knock-out of Ccny in the intestinal epithelium. We observed that Ccny-deficient mice did not exhibit any differences in cell proliferation and disease activity compared to wild-type littermates in the dextran sulfate sodium (DSS) colitis model. Complementary in vitro experiments showed that loss of CCNY in model IECs did not affect Wnt signaling, cell proliferation, or autophagy. Additionally, we observed that expression of the cyclin-Y-associated cyclin-dependent kinase (CDK) 14 is exceedingly low specifically in IEC. Collectively, these results suggest that cyclin Y does not contribute to intestinal epithelial homeostasis, possibly due to low levels of specific CDKs in these cells. Thus, it is unlikely that CCNY mutations are causatively involved in IBD pathogenesis.
Open AccessThe Candidate IBD Risk Gene CCNY Is Dispensable for Intestinal Epithelial Homeostasis
The CCNY gene, which encodes cyclin Y, has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Cyclin Y promotes Wnt/β-catenin signaling and autophagy, which are critical for intestinal epithelial cell (IEC) homeostasis, and may thereby contribute to wound repair in colitis. However, whether cyclin Y has an essential function in IECs is unknown. We, therefore, investigated the epithelial injury response and mucosal regeneration in mice with conditional knock-out of Ccny in the intestinal epithelium. We observed that Ccny-deficient mice did not exhibit any differences in cell proliferation and disease activity compared to wild-type littermates in the dextran sulfate sodium (DSS) colitis model. Complementary in vitro experiments showed that loss of CCNY in model IECs did not affect Wnt signaling, cell proliferation, or autophagy. Additionally, we observed that expression of the cyclin-Y-associated cyclin-dependent kinase (CDK) 14 is exceedingly low specifically in IEC. Collectively, these results suggest that cyclin Y does not contribute to intestinal epithelial homeostasis, possibly due to low levels of specific CDKs in these cells. Thus, it is unlikely that CCNY mutations are causatively involved in IBD pathogenesis.
- 24 February 2018
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 24 (4) , 792-805
A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
Peroxisome proliferator–activated receptor–gamma (PPARγ) exerts anti-inflammatory effects and is therefore a potential target in ulcerative colitis (UC). A novel PPARγ agonist (AS002) developed for local action was evaluated ex vivo in biopsies from UC patients and in vivo in mice with low-grade dextran sodium sulfate (DSS)– and trinitrobenzene sulfonic acid (TNBS)–induced colitis. Colonic biopsies from UC patients (n = 18) and healthy controls (n = 6) were incubated with AS002 or rosiglitazone (positive control) to measure mRNA expression of the PPARγ-responsive gene ADIPOPHILIN and protein levels of UC-related cytokines (enzyme-linked immunosorbent assay). AS002 absorption was determined in the colonic mucosa of UC patients. DSS-colitis mice received PPARγ agonists or vehicle daily by intrarectal administration starting 2 days before induction of colitis (preventive) or from days 3 to 8 (curative). Myeloperoxidase (MPO) and cytokine levels in colonic mucosa were determined. In addition, AS002 effects were studied in TNBS colitis. AS002 displayed an absorption pattern of a lipophilic drug totally metabolized in the mucosa. AS002 and rosiglitazone increased ADIPOPHILIN mRNA expression (3-fold) and decreased TNF-α, IL-1β, and IL-13 levels in human UC biopsies. In DSS, in both preventive and curative treatment and in TNBS colitis, AS002 protected against macroscopic and histological damage and lowered MPO and TNF-α, IL-1β, and IL-13 levels. AS002 triggers anti-inflammatory PPARγ activity in the human colonic mucosa of UC patients and prevents and reverses colitis in mice. Our data suggest that AS002 has potential for topical maintenance treatment of UC, which warrants further studies in vivo in patients.
- 24 February 2018
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 24 (4) , 792-805
A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
Peroxisome proliferator–activated receptor–gamma (PPARγ) exerts anti-inflammatory effects and is therefore a potential target in ulcerative colitis (UC). A novel PPARγ agonist (AS002) developed for local action was evaluated ex vivo in biopsies from UC patients and in vivo in mice with low-grade dextran sodium sulfate (DSS)– and trinitrobenzene sulfonic acid (TNBS)–induced colitis. Colonic biopsies from UC patients (n = 18) and healthy controls (n = 6) were incubated with AS002 or rosiglitazone (positive control) to measure mRNA expression of the PPARγ-responsive gene ADIPOPHILIN and protein levels of UC-related cytokines (enzyme-linked immunosorbent assay). AS002 absorption was determined in the colonic mucosa of UC patients. DSS-colitis mice received PPARγ agonists or vehicle daily by intrarectal administration starting 2 days before induction of colitis (preventive) or from days 3 to 8 (curative). Myeloperoxidase (MPO) and cytokine levels in colonic mucosa were determined. In addition, AS002 effects were studied in TNBS colitis. AS002 displayed an absorption pattern of a lipophilic drug totally metabolized in the mucosa. AS002 and rosiglitazone increased ADIPOPHILIN mRNA expression (3-fold) and decreased TNF-α, IL-1β, and IL-13 levels in human UC biopsies. In DSS, in both preventive and curative treatment and in TNBS colitis, AS002 protected against macroscopic and histological damage and lowered MPO and TNF-α, IL-1β, and IL-13 levels. AS002 triggers anti-inflammatory PPARγ activity in the human colonic mucosa of UC patients and prevents and reverses colitis in mice. Our data suggest that AS002 has potential for topical maintenance treatment of UC, which warrants further studies in vivo in patients.
- 9 February 2018
- Published by Springer Nature in Higher Education Policy
- Vol. 32 (2) , 273-296
Well-Being of Early-Career Researchers: Insights from a Swedish Survey
- 9 February 2018
- Published by Springer Nature in Higher Education Policy
- Vol. 32 (2) , 273-296
Well-Being of Early-Career Researchers: Insights from a Swedish Survey
- 11 October 2017
- Published by Springer Nature in Brain Structure and Function
- Vol. 223 (2) , 883-895
Maternal high-fat diet and early life stress differentially modulate spine density and dendritic morphology in the medial prefrontal cortex of juvenile and adult rats
The medial prefrontal cortex (mPFC) is a key area for the regulation of numerous brain functions including stress response and cognitive processes. This brain area is also particularly affected by adversity during early life. Using an animal model in rats, we recently demonstrated that maternal exposure to a high-fat diet (HFD) prevents maternal separation (MS)-induced gene expression alterations in the developing PFC and attenuates several long-term deleterious behavioral effects of MS. In the present study, we ask whether maternal HFD could protect mPFC neurons of pups exposed to early life stress by examining dendritic morphology and spine density in juvenile [postnatal day (PND) 21] and adult rats submitted to MS. Dams were fed either a control or an HFD throughout gestation and lactation, and pups were submitted to MS from PND2 to PND14. We report that maternal HFD prevents MS-induced spine loss at PND21 and dendritic atrophy at adulthood. Furthermore, we show in adult MS rats that PFC-dependent memory extinction deficits are prevented by maternal HFD. Finally, perinatal HFD exposure reverses gut leakiness following stress in pups and seems to exert an anti-stress effect in dams. Overall, our work demonstrates that maternal HFD affects the developing brain and suggests that nutrition, possibly through gut–brain interactions, could modulate mPFC sensitivity to early stress.
- 11 October 2017
- Published by Springer Nature in Brain Structure and Function
- Vol. 223 (2) , 883-895
Maternal high-fat diet and early life stress differentially modulate spine density and dendritic morphology in the medial prefrontal cortex of juvenile and adult rats
The medial prefrontal cortex (mPFC) is a key area for the regulation of numerous brain functions including stress response and cognitive processes. This brain area is also particularly affected by adversity during early life. Using an animal model in rats, we recently demonstrated that maternal exposure to a high-fat diet (HFD) prevents maternal separation (MS)-induced gene expression alterations in the developing PFC and attenuates several long-term deleterious behavioral effects of MS. In the present study, we ask whether maternal HFD could protect mPFC neurons of pups exposed to early life stress by examining dendritic morphology and spine density in juvenile [postnatal day (PND) 21] and adult rats submitted to MS. Dams were fed either a control or an HFD throughout gestation and lactation, and pups were submitted to MS from PND2 to PND14. We report that maternal HFD prevents MS-induced spine loss at PND21 and dendritic atrophy at adulthood. Furthermore, we show in adult MS rats that PFC-dependent memory extinction deficits are prevented by maternal HFD. Finally, perinatal HFD exposure reverses gut leakiness following stress in pups and seems to exert an anti-stress effect in dams. Overall, our work demonstrates that maternal HFD affects the developing brain and suggests that nutrition, possibly through gut–brain interactions, could modulate mPFC sensitivity to early stress.
- Open Access
- 14 September 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (9) , e0136048
Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress
The present study aimed at detecting the exogenously applied probiotic Lactobacillus farciminis in rats, after exposure to IBS-like chronic stress, based on 4-day Water Avoidance Stress (WAS). The presence of L. farciminis in both ileal and colonic mucosal tissues was demonstrated by FISH and qPCR, with ileum as the preferential niche, as for the SFB population. A different spatial distribution of the probiotic was observed: in the ileum, bacteria were organized in micro-colonies more or less close to the epithelium whereas, in the colon, they were mainly visualized far away from the epithelium. When rats were submitted to WAS, the L. farciminis population substantially decreased in both intestinal regions, due to a stress-induced increase in colonic motility and defecation, rather than a modification of bacterial binding to the intestinal mucin Muc2.
- 14 September 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (9) , e0136048
Open AccessSpatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress
The present study aimed at detecting the exogenously applied probiotic Lactobacillus farciminis in rats, after exposure to IBS-like chronic stress, based on 4-day Water Avoidance Stress (WAS). The presence of L. farciminis in both ileal and colonic mucosal tissues was demonstrated by FISH and qPCR, with ileum as the preferential niche, as for the SFB population. A different spatial distribution of the probiotic was observed: in the ileum, bacteria were organized in micro-colonies more or less close to the epithelium whereas, in the colon, they were mainly visualized far away from the epithelium. When rats were submitted to WAS, the L. farciminis population substantially decreased in both intestinal regions, due to a stress-induced increase in colonic motility and defecation, rather than a modification of bacterial binding to the intestinal mucin Muc2.
- Open Access
- 15 August 2014
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 307 (4) , G420-G429
Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment
Despite well-known intestinal epithelial barrier impairment and visceral hypersensitivity in irritable bowel syndrome (IBS) patients and IBS-like models, structural and physical changes in the mucus layer remain poorly understood. Using a water avoidance stress (WAS) model, we aimed at evaluating whether 1) WAS modified gut permeability, visceral sensitivity, mucin expression, biochemical structure of O-glycans, and related mucus physical properties, and 2) whether Lactobacillus farciminis treatment prevented these alterations. Wistar rats received orally L. farciminis or vehicle for 14 days; at day 10, they were submitted to either sham or 4-day WAS. Intestinal paracellular permeability and visceral sensitivity were measured in vivo. The number of goblet cells and Muc2 expression were evaluated by histology and immunohistochemistry, respectively. Mucosal adhesion of L. farciminis was determined ex situ. The mucin O-glycosylation profile was obtained by mass spectrometry. Surface imaging of intestinal mucus was performed at nanoscale by atomic force microscopy. WAS induced gut hyperpermeability and visceral hypersensitivity but did not modify either the number of intestinal goblet cells or Muc2 expression. In contrast, O-glycosylation of mucins was strongly affected, with the appearance of elongated polylactosaminic chain containing O-glycan structures, associated with flattening and loss of the mucus layer cohesive properties. L. farciminis bound to intestinal Muc2 and prevented WAS-induced functional alterations and changes in mucin O-glycosylation and mucus physical properties. WAS-induced functional changes were associated with mucus alterations resulting from a shift in O-glycosylation rather than from changes in mucin expression. L. farciminis treatment prevented these alterations, conferring epithelial and mucus barrier strengthening.
- 15 August 2014
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 307 (4) , G420-G429
Open AccessStress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment
Despite well-known intestinal epithelial barrier impairment and visceral hypersensitivity in irritable bowel syndrome (IBS) patients and IBS-like models, structural and physical changes in the mucus layer remain poorly understood. Using a water avoidance stress (WAS) model, we aimed at evaluating whether 1) WAS modified gut permeability, visceral sensitivity, mucin expression, biochemical structure of O-glycans, and related mucus physical properties, and 2) whether Lactobacillus farciminis treatment prevented these alterations. Wistar rats received orally L. farciminis or vehicle for 14 days; at day 10, they were submitted to either sham or 4-day WAS. Intestinal paracellular permeability and visceral sensitivity were measured in vivo. The number of goblet cells and Muc2 expression were evaluated by histology and immunohistochemistry, respectively. Mucosal adhesion of L. farciminis was determined ex situ. The mucin O-glycosylation profile was obtained by mass spectrometry. Surface imaging of intestinal mucus was performed at nanoscale by atomic force microscopy. WAS induced gut hyperpermeability and visceral hypersensitivity but did not modify either the number of intestinal goblet cells or Muc2 expression. In contrast, O-glycosylation of mucins was strongly affected, with the appearance of elongated polylactosaminic chain containing O-glycan structures, associated with flattening and loss of the mucus layer cohesive properties. L. farciminis bound to intestinal Muc2 and prevented WAS-induced functional alterations and changes in mucin O-glycosylation and mucus physical properties. WAS-induced functional changes were associated with mucus alterations resulting from a shift in O-glycosylation rather than from changes in mucin expression. L. farciminis treatment prevented these alterations, conferring epithelial and mucus barrier strengthening.